Cite

HARVARD Citation

    Gao, Z. et al. (2020). A CD44-targeted Cu(ii) delivery 2D nanoplatform for sensitized disulfiram chemotherapy to triple-negative breast cancer. Nanoscale. 12 (15), pp. 8139-8146. [Online]. 
  
Back to record